Skip to main content

Table 1 Correlation of PinX1 expression in tissue with patients’ clinicopathological variables in 187 cases of UCB

From: PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway

   PinX1 expression (%)
Variables All cases (N = 187) Negative expression (N = 83) Positive expression (N = 104) P valuea
Age(years)     0.456
≤60b 80 33(41.3) 47(58.8)  
>60 107 50(46.7) 57(53.3)  
Gender     0.212
Male 166 71(42.8) 95(57.2)  
Female 21 12(57.1) 9(42.9)  
Tumor multiplicity     <0.001
Unifocal 79 17(21.5) 62(78.5)  
Multifocal 108 66(61.1) 42(38.9)  
WHO grade     0.844
G1 46 19(41.3) 27(58.7)  
G2 66 29(43.9) 37(56.1)  
G3 75 35(46.7) 40(53.3)  
pT status     0.404
pT1 35 13(64.0) 22(36.0)  
pT2 95 38(54.5) 57(45.5)  
pT3 37 20(50.0) 17(50.0)  
pT4 20 12(37.5) 8(62.5)  
pN status     0.023
pN- 157 64(40.8) 93(59.2)  
pN+ 30 19(63.3) 11(36.7)  
ki-67 index     0.004
≥50% 95 52(54.7) 43(45.3)  
<50% 92 31(33.7) 61(66.3)  
  1. aChi-square test. bmean age. UCB: urothelial carcinoma of bladder.